Paul Rennie is a co-founder and Director of Laboratory Research for the Prostate Centre at Vancouver General Hospital, Canada’s largest integrated, multi-disciplinary, prostate disease-specific research and treatment facility. He is one of Canada’s leading experts in prostate cancer research whose work on characterizing androgen receptors and their functional interactions with chromatin and DNA has contributed to our understanding of how the growth of the prostate and prostate cancers are controlled by androgens. This has resulted in new protocols for treating prostate cancer, which are used around the world.